121 related articles for article (PubMed ID: 38331373)
21. Visual detection of high-risk HPV16 and HPV18 based on loop-mediated isothermal amplification.
Fan Z; Feng X; Zhang W; Li N; Zhang X; Lin JM
Talanta; 2020 Sep; 217():121015. PubMed ID: 32498911
[TBL] [Abstract][Full Text] [Related]
22. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
23. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
[TBL] [Abstract][Full Text] [Related]
24. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
25. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
[TBL] [Abstract][Full Text] [Related]
26. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
27. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
Zhao Y; Cao X; Tang J; Zhou L; Gao Y; Wang J; Zheng Y; Yin S; Wang Y
Mol Cell Probes; 2012 Apr; 26(2):66-72. PubMed ID: 22293505
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel Multiple Cross-Linking Spiral Amplification for Rapid and Sensitive Detection of HPV16 DNA.
Zhang D; Liu D; Liu B; Ma X
J Microbiol Biotechnol; 2021 Apr; 31(4):610-620. PubMed ID: 33526756
[TBL] [Abstract][Full Text] [Related]
30. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
31. Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
Rohatensky MG; Livingstone DM; Mintchev P; Barnes HK; Nakoneshny SC; Demetrick DJ; Dort JC; van Marle G
BMC Cancer; 2018 Feb; 18(1):166. PubMed ID: 29422018
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
Ossel J; Litjens RJ; Reijans M; Brink AA; Ummelen M; Ramaekers FC; Hopman AH; Simons G
J Clin Virol; 2014 Dec; 61(4):540-7. PubMed ID: 25453331
[TBL] [Abstract][Full Text] [Related]
33. Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.
Rungkamoltip P; Temisak S; Piboonprai K; Japrung D; Thangsunan P; Chanpanitkitchot S; Chaowawanit W; Chandeying N; Tangjitgamol S; Iempridee T
Exp Biol Med (Maywood); 2021 Mar; 246(6):654-666. PubMed ID: 33307803
[TBL] [Abstract][Full Text] [Related]
34. Detection of high-risk human papillomavirus type 16 and 18 using isothermal helicase-dependent amplification.
Barbieri D; Venturoli S; Rösl F; Rincon-Orozco B
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):178-82. PubMed ID: 24666707
[TBL] [Abstract][Full Text] [Related]
35. Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
Nakowong P; Chatchawal P; Chaibun T; Boonapatcharoen N; Promptmas C; Buajeeb W; Lee SY; Jearanaikoon P; Lertanantawong B
Talanta; 2024 Mar; 269():125495. PubMed ID: 38043336
[TBL] [Abstract][Full Text] [Related]
36. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.
Roberts CC; Tadesse AS; Sands J; Halvorsen T; Schofield TL; Dalen A; Skjeldestad FE; Jansen KU
J Clin Virol; 2006 Aug; 36(4):277-82. PubMed ID: 16765639
[TBL] [Abstract][Full Text] [Related]
37. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification.
Saetiew C; Limpaiboon T; Jearanaikoon P; Daduang S; Pientong C; Kerdsin A; Daduang J
J Virol Methods; 2011 Dec; 178(1-2):22-30. PubMed ID: 21903136
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
[TBL] [Abstract][Full Text] [Related]
39. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
[TBL] [Abstract][Full Text] [Related]
40. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
